Rehmann Capital Advisory Group’s Teladoc Health TDOC Stock Holding History

Rehmann Capital Advisory Group’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-772	Closed	-$374K	–	528
2020 Q4	$374K	Buy	+772	New	+$157K	0.04%	318
2019 Q3	–	Sell	-1,018	Closed	-$67.6K	–	2085
2019 Q2	$67.6K	Sell	1,018 -5,992	-85%	-$349K	0.01%	731
2019 Q1	$390K	Buy	7,010 +6,588	+1,561%	+$402K	0.05%	272
2018 Q4	$20.9K	Buy	422 +13	+3%	+$795	﹤0.01%	854
2018 Q3	$35.3K	Hold	409	–	–	﹤0.01%	935
2018 Q2	$23.7K	Sell	409 -4,113	-91%	-$201K	﹤0.01%	1039
2018 Q1	$182K	Buy	+4,522	New	+$171K	0.03%	396

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $39.8M AUM 27.89% 1-Year Est. Return

Rehmann Capital Advisory Group's TDOC Position: Q1 2021 in Review

Rehmann Capital Advisory Group sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 772 shares — an estimated $374K sold.

Rehmann Capital Advisory Group first reported a position in TDOC in Q1 2018 and held it in 7 quarters. The position peaked at $390K in Q1 2019. 890 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

Rehmann Capital Advisory Group reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
Rehmann Capital Advisory Group sold 772 Teladoc Health shares in Q1 2021, an estimated $374K.
Rehmann Capital Advisory Group first reported a position in Teladoc Health in Q1 2018 and held it in 7 quarters.
Rehmann Capital Advisory Group's Teladoc Health position peaked at $390K in Q1 2019.
890 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2021, filed 26 May 2021.